CARE Ratings to host analyst meet on August 12
CARE Ratings Limited announced an analyst meet for August 12, 2026, at EMKAY Confluence 2026 in Mumbai. The session starts at 10:00 AM IST and will focus on publicly available information. An Investor Presentation is available on the company's website for stakeholder review.

*this image is generated using AI for illustrative purposes only.
CARE Ratings Limited will host an analyst and institutional investor meet on August 12, 2026, providing stakeholders with an opportunity to discuss the company’s performance and strategic direction. The event is part of the EMKAY Confluence 2026 conference and will take place in Mumbai, offering investors direct access to management insights based on publicly available data.
The meet is scheduled to begin at 10:00 AM IST. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, CARE Ratings Limited issued the intimation to BSE Limited and The National Stock Exchange of India Ltd. on August 7, 2026. The company noted that discussions during the session will be strictly limited to publicly available information.
Event Details
The schedule for the investor interaction is outlined below:
| Date | Time | Organized by | Location |
|---|---|---|---|
| August 12, 2026 | 10:00 AM Onwards | EMKAY Confluence 2026 | Mumbai |
Manoj Kumar CV, Company Secretary & Compliance Officer, signed the disclosure. The company cautioned that the schedule may undergo changes due to exigencies on the part of the investor or the company.
Investor Resources
To assist participants, CARE Ratings Limited has already placed its Investor Presentation on its official website. The document provides a comprehensive overview of the company’s financial health and operational metrics, serving as the basis for the upcoming discussion. Investors are advised to review this material prior to the meet to facilitate informed dialogue with management.
Historical Stock Returns for CARE Ratings
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.10% | +2.44% | +4.45% | +6.19% | +6.86% | +147.06% |
How might the strategic initiatives outlined in CARE Ratings' investor presentation influence its market share against competitors like CRISIL and ICRA in 2027?
What specific regulatory changes in India's credit rating sector could impact CARE Ratings' revenue models following the EMKAY Confluence discussions?
Will management address any plans for international expansion or acquisitions to diversify revenue streams beyond the domestic Indian market?


































